Erik R Rasmussen
Overview
Explore the profile of Erik R Rasmussen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
370
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Y, Amaladas N, OMahony M, Manro J, Inigo I, Li Q, et al.
PLoS One
. 2022 Jul;
17(7):e0268244.
PMID: 35849586
Prolonged activation of vascular endothelial growth factor receptor-2 (VEGFR-2) due to mis-regulation of the VEGF pathway induces aberrant blood vessel expansion, which supports growth and survival of solid tumors. Therapeutic...
2.
van der Heijden M, Powles T, Petrylak D, de Wit R, Necchi A, Sternberg C, et al.
Nat Commun
. 2022 Apr;
13(1):1878.
PMID: 35388003
The RANGE study (NCT02426125) evaluated ramucirumab (an anti-VEGFR2 monoclonal antibody) in patients with platinum-refractory advanced urothelial carcinoma (UC). Here, we use programmed cell death-ligand 1 (PD-L1) immunohistochemistry (IHC) and transcriptome...
3.
Schaer D, Geeganage S, Amaladas N, Lu Z, Rasmussen E, Sonyi A, et al.
Clin Cancer Res
. 2019 Aug;
25(23):7175-7188.
PMID: 31409612
Purpose: Combination strategies leveraging chemotherapeutic agents and immunotherapy have held the promise as a method to improve benefit for patients with cancer. However, most chemotherapies have detrimental effects on immune...
4.
Schaer D, Beckmann R, Dempsey J, Huber L, Forest A, Amaladas N, et al.
Cell Rep
. 2018 Mar;
22(11):2978-2994.
PMID: 29539425
Abemaciclib, an inhibitor of cyclin dependent kinases 4 and 6 (CDK4/6), has recently been approved for the treatment of hormone receptor-positive breast cancer. In this study, we use murine syngeneic...
5.
Todd R, Rasmussen E, Wood C, Levy F, Hay D
J Am Acad Child Adolesc Psychiatry
. 2004 Apr;
43(5):588-97.
PMID: 15100565
Objective: To determine the impact of including sluggish cognitive tempo items on the factor and latent class structure of attention-deficit/hyperactivity disorder (ADHD) subtypes in boys and girls. Method: Parent report...
6.
Rasmussen E, Neuman R, Heath A, Levy F, Hay D, Todd R
J Child Psychol Psychiatry
. 2004 Apr;
45(3):589-98.
PMID: 15055377
Background: Findings from family and twin-based studies of Attention Deficit/Hyperactivity Disorder (ADHD) have indicated that inattentive and combined subtypes cluster together among sibling pairs who both express ADHD symptoms. The...
7.
Rasmussen E, Neuman R, Heath A, Levy F, Hay D, Todd R
J Child Psychol Psychiatry
. 2002 Nov;
43(8):1018-28.
PMID: 12455923
Background: Previous efforts to subtype Attention-Deficit/Hyperactivity Disorder (ADHD) using latent class analysis (LCA) applied to DSM-IV symptom profiles of adolescent female twins from Missouri (USA) have identified distinct classes within...
8.
Rasmussen E, Todd R, Neuman R, Heath A, Reich W, Rohde L
J Child Psychol Psychiatry
. 2002 Sep;
43(6):797-805.
PMID: 12236614
Background: The goal of this study is to gauge the consistency of Attention Deficit/Hyperactivity Disorder (ADHD) latent class models that are generated by different informants such as adolescents and parents....